Navigation Links
Particle Sciences and IES Engineers Cooperate on High Potency Compound Handling Capabilities
Date:12/8/2009

BETHLEHEM, Pa., Dec. 8 /PRNewswire/ -- Particle Sciences Inc. (PSI), a leading pharmaceutical CRO, has further expanded their High Potency Compound (HPC) handling capabilities through a unique relationship with IES Engineers. "HPCs are an increasing part of our business and an area that many CROs are unwilling to make the necessary investment in to safely handle them," says Dr. Robert Lee, PSI's VP Pharmaceutical Development. "Each HPC is different and requires its own set of considerations. Companies need both the physical and staffing infrastructure to work with them. For PSI, the key task was proper strategic staffing maximizing not only our ability to work with HPCs but to do it in a way that was commercially viable," Dr. Lee went on to say.

Under the arrangement, IES Engineers will be responsible for evaluating incoming materials and placing them into exposure control bands, which specify the safe procedures around their handling and processing. IES will also be involved in specific design and implementation of HPC related procedures. In this way, PSI gains the experience and vast capabilities of one of the world's leaders in potent compound safety. According to George Petroka, Director BioPharma/EHS Services at IES Engineers, "This is the standard approach adopted by big Pharma for working with HPCs, but is not as common outside of that group, and demonstrates PSI's dedication to working with HPCs and providing innovative HPC services. By using IES Engineers in this capacity, PSI is assuring their clients of industry-leading practices and careful review of procedures. It would be very difficult for a midsized company to acquire the level of expertise we can provide."

Dr. Lee further stated, "Our core areas are nano-based systems and difficult to formulate APIs both in semisolids and combination products. Obviously, a great number of these products are HPCs such as oncology agents and various hormone preparations. Expanding this capability only makes sense as we look for better ways to serve our client base."

IES is a fully integrated engineering and environmental, health, and safety consulting firm providing an extensive range of technical services to the bio/pharmaceutical, healthcare, specialty chemical, food, printing, and industrial sectors. Client speed to market, aggressive schedule deadlines, quality, regulatory compliance, and best management practices drive our project performance. As the consultant of choice, our primary focus is to improve our clients' financial performance and reduce liabilities while helping them maximize their competitive advantage.

Particle Sciences is an integrated provider of drug development services. Particle Sciences focuses on emulsions, gels, particulates and drug/device combination products with additional specialized capabilities in topical and mucosal drug delivery. Through a full range of formulation, analytic, and manufacturing services, Particle Sciences provides pharmaceutical companies with a complete and seamless development solution that minimizes the time and risk between discovery and the clinic. The company was founded in 1991 and is headquartered in Bethlehem, Pennsylvania. Visit http://www.particlesciences.com, email info@particlesciences.com or contact us at (610) 861-4701 for information.


Contact:
Maureen Cochran
mcochran@particlesciences.com

SOURCE Particle Sciences Inc.


'/>"/>
SOURCE Particle Sciences Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Targeted Nanoparticles Offer Promise in the Battle Against Cancer
2. IBA and Elekta Initiate Global Particle Therapy Program at ASTRO
3. Recent Findings from the Framingham Offspring Study Show Low Numbers of LDL Particles (LDL-P) by NMR are Associated With Fewer Heart Disease Related Events than Equivalently Low Levels of LDL Cholesterol (LDL-C).(1)
4. Celator(R) Pharmaceuticals Successfully Uses Nanoparticles to Administer Hydrophobic Drug Combinations
5. Ion Mobility Diagnostic Test from Quest Diagnostics is First to Provide Direct Physical Measurement of Lipoprotein Particles, Cardiovascular Disease Indicators, Study Finds
6. Particle Sciences Expands Its Combination Product Capabilities
7. Novavax Reports Positive Preclinical Results for a Novel, Broadly Cross-Protective H5N1 Pandemic Influenza Virus-like Particle (VLP) Vaccine Candidate
8. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
9. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
10. Advanced Life Sciences Collaborates with U.S. Government to Study Cethromycin as Treatment for Anthrax and Other High-Priority Biodefense Agents
11. ImmuneRegen BioSciences, Inc. Demonstrates Radilex(TM) Increases Disease-Fighting White Blood Cells
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/9/2017)... WASHINGTON , May 9, 2017  Demonstrating ... the board of directors for the Pharmaceutical Research ... criteria for membership. Biopharmaceutical companies will now have ... in order to be eligible to join PhRMA. ... criteria, the board is sending a clear message ...
(Date:5/9/2017)... Ore. , May 9, 2017  Semler ... that provides technology solutions to improve the clinical ... financial results for the first quarter ended March ... our products enable our customers to identify when ... to intervene before events like heart attacks or ...
(Date:5/8/2017)... FLINT, Mich. , May 8, 2017  Diplomat ... WRB Communications, Inc. ("WRB"), a health care ... . WRB specializes in relationship management ... organizations. WRB will ... of Diplomat,s commercialization support services for manufacturers, biotech firms, ...
Breaking Medicine Technology:
(Date:5/23/2017)... ... May 23, 2017 , ... PM360, the premier information ... announced the winners of its 3rd Annual ELITE Awards. The ELITE (Exceptional • ... the healthcare industry today. , Out of more than 500 submissions, 100 winners ...
(Date:5/23/2017)... ... May 23, 2017 , ... London, May 23, 2017: Walter Schindler, ... this month as a Guest Speaker and Contributor to a weeklong series of classes, ... Purpose. , Walter Schindler and SAIL Capital have received ...
(Date:5/23/2017)... ... May 23, 2017 , ... ... chat as a standard feature on its secure clinical communication platform. The platform ... to video depending on the type and urgency of a situation. , ...
(Date:5/23/2017)... ... May 23, 2017 , ... Therachat , a smart guided journaling ... infographic on the current state of anxiety in support of National Mental Health Awareness ... in April 2017 and benchmarked general anxiety levels as well as identified the top ...
(Date:5/22/2017)... ... May 22, 2017 , ... Today, Our Urgent Care ... with a public ribbon cutting ceremony. Since opening over a month ago, ... to the emergency room. The new Our Urgent Care walk-in clinic is located ...
Breaking Medicine News(10 mins):